These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38902929)
1. Piperacillin/tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing. Lodise TP; Bhavnani SM; Ambrose PG; Sader HS; Andes DR; Pogue JM Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38902929 [TBL] [Abstract][Full Text] [Related]
2. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745 [TBL] [Abstract][Full Text] [Related]
3. Ceftolozane/Tazobactam Activity Against Drug-Resistant Pfaller M; Shortridge D; Chen WT; Sader H; Castanheira M Infect Drug Resist; 2022; 15():6739-6753. PubMed ID: 36444213 [TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of piperacillin-tazobactam and temocillin against third-generation cephalosporin-resistant, carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae. Kresken M; Pfeifer Y; Werner G GMS Infect Dis; 2021; 9():Doc08. PubMed ID: 35106270 [TBL] [Abstract][Full Text] [Related]
5. Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam. Belley A; Morrissey I; Hawser S; Kothari N; Knechtle P J Glob Antimicrob Resist; 2021 Jun; 25():93-101. PubMed ID: 33746112 [TBL] [Abstract][Full Text] [Related]
12. Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners. Dazio V; Nigg A; Schmidt JS; Brilhante M; Campos-Madueno EI; Mauri N; Kuster SP; Brawand SG; Willi B; Endimiani A; Perreten V; Schuller S One Health; 2021 Dec; 13():100322. PubMed ID: 34522760 [TBL] [Abstract][Full Text] [Related]
13. A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints. Gupta V; Yu KC; Pogue JM; Watts JA; Clancy CJ Microbiol Spectr; 2022 Jun; 10(3):e0115822. PubMed ID: 35638777 [TBL] [Abstract][Full Text] [Related]
15. Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance. Abdelraouf K; Chavda KD; Satlin MJ; Jenkins SG; Kreiswirth BN; Nicolau DP Int J Antimicrob Agents; 2020 Mar; 55(3):105885. PubMed ID: 31923568 [TBL] [Abstract][Full Text] [Related]
16. Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018. Shortridge D; Streit J; Pfaller M; Tulloch M; Chen WT; Castanheira M J Glob Antimicrob Resist; 2022 Dec; 31():98-103. PubMed ID: 35988706 [TBL] [Abstract][Full Text] [Related]
17. Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommendations. Bixby ML; Salay JM; Krueger AR; Mathers AJ; Hirsch EB Microbiol Spectr; 2023 Mar; 11(2):e0336322. PubMed ID: 36877020 [TBL] [Abstract][Full Text] [Related]
18. Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019. Jean SS; Lu MC; Ho MW; Ko WC; Hsueh PR; Int J Antimicrob Agents; 2022 Mar; 59(3):106521. PubMed ID: 35066144 [TBL] [Abstract][Full Text] [Related]
19. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study. Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A; Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672 [TBL] [Abstract][Full Text] [Related]
20. Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers. Sader HS; Mendes RE; Kimbrough JH; Kantro V; Castanheira M Open Forum Infect Dis; 2023 Feb; 10(2):ofad058. PubMed ID: 36861086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]